Filing Details

Accession Number:
0001127602-21-018560
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-01 17:55:29
Reporting Period:
2021-05-28
Accepted Time:
2021-06-01 17:55:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752060 R John Liddicoat Medtronic Plc
710 Medtronic Pkwy, Ms Lc300
Minneapolis MN 55432
Evp & President Of Americas No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-05-28 17,095 $78.00 59,646 No 4 M Direct
Ordinary Shares Acquisiton 2021-05-28 1,283 $78.00 60,929 No 4 M Direct
Ordinary Shares Acquisiton 2021-05-28 1,136 $88.06 62,065 No 4 M Direct
Ordinary Shares Acquisiton 2021-05-28 15,142 $88.06 77,207 No 4 M Direct
Ordinary Shares Disposition 2021-05-28 34,656 $126.65 42,551 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2021-05-28 17,095 $0.00 17,095 $78.00
Ordinary Shares Stock Option (Right to Buy) Disposition 2021-05-28 1,283 $0.00 1,283 $78.00
Ordinary Shares Stock Option (Right to Buy) Disposition 2021-05-28 1,136 $0.00 1,136 $88.06
Ordinary Shares Stock Option (Right to Buy) Disposition 2021-05-28 15,142 $0.00 15,142 $88.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-08-03 2025-08-03 No 4 M Direct
0 2016-08-03 2025-08-03 No 4 M Direct
0 2017-08-01 2026-08-01 No 4 M Direct
0 2017-08-01 2026-08-01 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. This balance increased by 562 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
  3. These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date.